Valuation: AstraZeneca PLC

Market Cap 264B 229B 214B 196B 370B 25,138B 377B 2,523B 988B 12,536B 991B 969B 41,349B P/E 2026 *
21.8x
P/E 2027 * 19x
Enterprise Value 284B 247B 230B 211B 399B 27,050B 406B 2,715B 1,063B 13,489B 1,066B 1,042B 44,493B EV / Sales 2026 *
4.48x
EV / Sales 2027 * 4.13x
Free-Float
96.63%
Yield 2026 *
1.96%
Yield 2027 * 2.07%
1 day-9.30%
1 week-10.77%
Current month-8.96%
1 month-20.45%
3 months-13.73%
6 months-16.76%
Current year-16.61%
1 week 11,414
Extreme 11414
13,164
1 month 10,524
Extreme 10524
14,526
Current year 10,524
Extreme 10524
15,732
1 year 10,524
Extreme 10524
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 30/09/2012
Director of Finance/CFO 52 31/07/2021
Compliance Officer - 31/12/2022
Director TitleAgeSince
Director/Board Member 70 05/04/1999
Director/Board Member 66 30/09/2012
Director/Board Member 65 26/04/2017
Date Insider Type Main position Quantity % Market Cap.
06/07/26 Free

See Remarks

2 0.0000%
22/12/25 Sell

Director

297 0.0000%
19/12/25 Don

Director

5,735 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-8.96%-10.77%+3.27%+5.50% 264B
-2.80%-6.82%+45.11%+148.43% 1,024B
-1.31%-4.99%+47.73%+48.08% 618B
-1.93%-4.33%+24.65%+64.91% 443B
+0.68%-1.14%+39.61%+33.36% 349B
-1.66%-3.13%+31.63%+39.79% 297B
-1.37%-7.41%-3.42%-43.67% 209B
-1.98%+0.81%+25.62%+64.41% 208B
-0.55%-0.48%+13.44%+71.98% 162B
-0.42%+1.09%+5.99%-28.74% 143B
Average -1.91%-1.02%+23.36%+40.41% 371.63B
Weighted average by Cap. -2.02%-2.01%+31.85%+66.54%

Financials

2026 *2027 *
Net sales 63.28B 55B 51.35B 47.14B 88.88B 6,032B 90.43B 605B 237B 3,008B 238B 232B 9,921B 66.85B 58.1B 54.24B 49.8B 93.9B 6,372B 95.53B 640B 251B 3,178B 251B 246B 10,481B
Net income 12.09B 10.5B 9.81B 9B 16.97B 1,152B 17.27B 116B 45.28B 574B 45.39B 44.39B 1,895B 13.71B 11.92B 11.12B 10.21B 19.26B 1,307B 19.59B 131B 51.37B 652B 51.5B 50.36B 2,150B
Net Debt 20.05B 17.43B 16.27B 14.94B 28.17B 1,911B 28.66B 192B 75.14B 953B 75.33B 73.66B 3,144B 12.56B 10.92B 10.19B 9.36B 17.64B 1,197B 17.95B 120B 47.07B 597B 47.19B 46.14B 1,969B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
03/08/26 GBX 11,500.00 -8.96% 6,159,228
31/07/26 GBX 12,632.00 -0.69% 1,904,551
30/07/26 GBX 12,720.00 -3.15% 5,166,279
29/07/26 GBX 13,134.00 +1.50% 5,212,610
28/07/26 GBX 12,940.00 +0.40% 2,837,787
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
170.04USD
Average target price
212.43USD
Spread / Average Target
+24.93%

Quarterly revenue - Rate of surprise